News

June 1, 2020June 1, 2020

UK Health Agency Recommends Stelara for Moderately to Severely Active Ulcerative Colitis

News

The U.K. National Institute for Health and Care Excellence (NICE) has recommended the use of Stelara (ustekinumab) to treat patients with moderately to severely active ulcerative colitis specifically in adults when ... Read more

May 18, 2020May 18, 2020

Early Phase 2 Trial Data Support Safety, Efficacy of BBT-401 for Ulcerative Colitis

News, Ulcerative colitis

People with ulcerative colitis may benefit from the experimental oral therapy BBT-401, suggest early data from an ongoing Phase 2 clinical trial that also supports its good safety profile. BBT-401 is ... Read more

May 11, 2020May 11, 2020

Entyvio At-home Injection Approved in Europe to Treat Adults With IBD

Crohn's Disease, News, Ulcerative colitis

The European Commission has approved a subcutaneous (under-the-skin) formulation of Entyvio (vedolizumab) for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). This ... Read more

May 4, 2020May 4, 2020

Joint Study to Assess Effects of COVID-19 on Patients with IBD, Other Autoimmune Conditions

News

The Global Healthy Living Foundation (GHLF) has launched a study to evaluate the impact of the COVID-19 pandemic on patients with Crohn’s disease and ulcerative colitis, among other autoimmune diseases. ... Read more

April 20, 2020April 20, 2020

New Guidelines Issued on Treating IBD Patients During COVID-19 Pandemic

News

Leading experts have drafted new guidelines to aid gastroenterologists in the management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic, according to an American Gastroenterological Association (AGA) press ... Read more

April 13, 2020April 13, 2020

Etrasimod in Controlled Release Seen to Limit Heart Rate Changes, May Be Added to Trials

News

A controlled-release version of etrasimod could limit the changes in heart rate linked to an initial dose of this investigational medication, according to topline clinical trial data announced by Arena ... Read more

April 6, 2020April 6, 2020

Scientists Identify Biomarkers, Environmental Factors That May Lead to IBD Prevention

News

Researchers at Mount Sinai have identified new protein biomarkers of Crohn’s disease, and environmental factors that may increase a person’s risk of developing inflammatory bowel disease (IBD). Together, these findings ... Read more

March 30, 2020March 30, 2020

Gut Bacteria Adapt Their Behavior Depending on Where They Reside, Mouse Study Suggests

News

Bacteroides fragilis, bacteria known for their protective role in the gut, change their gene activity and behavior according to where in the gut they reside, a study in mice has ... Read more

March 23, 2020March 23, 2020

Infliximab Helps Gut Microbiome in Children with Crohn’s, Study Finds

News

Treatment with infliximab helps normalize the gut microbiome, soothing Crohn’s disease in children and adolescents, a study suggests. Longer studies are needed to understand if these medicines can fully restore ... Read more

March 20, 2020March 20, 2020

Algorithm Seen to Judge Colonoscopies, Predict UC Remission with High Accuracy

News

A new artificial intelligence (AI) algorithm evaluates colonoscopy exams with a level of accuracy equivalent to experts, scientists in Japan report. The AI algorithm they developed may also help physicians ... Read more